Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.
Amadio S, Apolloni S, D’Ambrosi N et al.
Editor’s note: Amadio and colleagues present an interesting and informative review. They discuss the relevance of purinergic transmembrane signaling for amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), two diseases with neurodegenerative and neuroinflammatory capacities.